| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -26.18M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FULC returned -44.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -66.1% |
| 1 year | -44.3% |
| 5 years | -87.1% |
| All-time high | $29.70 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FULC would be worth today ›No. Fulcrum Therapeutics, Inc. has not paid a dividend in the past 12 months.
Fulcrum Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol FULC.
Fulcrum Therapeutics, Inc. is part of the Healthcare sector.
Fulcrum Therapeutics, Inc. has a market cap of 292.22M USD, based on the latest quote.
Fulcrum Therapeutics, Inc. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
